GSK Velu, Chairman, Neuberg Diagnostics
Neuberg Diagnostics is planning to invest Rs 300 crore in India, the Middle East and Africa as part of its expansion plans.
The company having focus on new generation technologies in the diagnostics space, has already invested Rs 450 crore in acquiring laboratories in India and abroad and upgrading them.
Neuberg at present has 50 labs and 500 centres in the south and west India, and plans to increase the total count to 150 labs and 1,000 centres in the next three years.
An alliance of five top laboratories like Anand Diagnostic Laboratory, Supratech Micropath, Ehrlich lab, Global labs and Minerva Labs, the company plans to have three infrastructure models — global centre of excellence, regional reference centres and satellite centres.
It also wants to establish research centres in the US and European markets, to get access to latest technologies and bring it to India
